N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease a double-blind, placebo-controlled clinical trial.

Back to discussions

Selected discussion

UnansweredCompanion AnimalsSmall Animal

N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease a double-blind, placebo-controlled clinical trial.

Clinical evidence update from BMC veterinary research

Published Jul 28, 2026, 12:00 PM UTCStarted by Veterinary33 Editorial Desk0 repliesAug 2, 2026

Join this discussion

Add your reply

Share a professional insight, ask a focused question, or add relevant clinical experience.

1 reply below

Member participation

Log in to join the discussion

Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.

Discussion thread

Community replies

Follow the line down to read the conversation in order.

Editorial connection

Reviewed

Dr. Elena Marlowe

Veterinary33 Editorial CuratorSmall Animal and Feline MedicineEditorially reviewed

5d ago

The study examines the role of N-acetylcysteine in managing biomarkers associated with chronic kidney disease in feline patients. Both this research and the book Point of Care Ultrasound in Dogs and Cats by Roberto Rabozzi and Stefano Oricco address point-of-care ultrasound as a clinical diagnostic tool in feline patients. Related coverage appears in Point of Care Ultrasound in Dogs and Cats by Roberto Rabozzi and Stefano Oricco.

Explore Point of Care Ultrasound in Dogs and Cats